We are live on
!
Find out more
United Therapeutics
UTHR
UTHR
356 hedge funds and large institutions have $6.56B invested in United Therapeutics in 2020 Q4 according to their latest regulatory filings, with 68 funds opening new positions, 101 increasing their positions, 140 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
169% more call options, than puts
Call options by funds: $39.7M | Put options by funds: $14.7M
63% more funds holding in top 10
Funds holding in top 10: 8 → 13 (+5)
58% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 43
55% more capital invested
Capital invested by funds: $4.22B → $6.56B (+$2.34B)
7% more funds holding
Funds holding: 333 → 356 (+23)
2% more ownership
Funds ownership: 95.04% → 97.04% (+2%)
28% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 140
Holders
356
Holders Change
+23
Holders Change %
+6.91%
% of All Funds
6.3%
Holding in Top 10
13
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+62.5%
% of All Funds
0.23%
New
68
Increased
101
Reduced
140
Closed
43
Calls
$39.7M
Puts
$14.7M
Net Calls
+$25M
Net Calls Change
+$18M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$374M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$69.4M |
| 3 |
EP
Eversept Partners
New York
|
+$28.6M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$27.7M |
| 5 |
SCM
Scopia Capital Management
New York
|
+$27M |
